HMGB1 genetic polymorphisms in oral squamous cell carcinoma and oral lichen planus patients.

OBJECTIVES This study examined the single nucleotide polymorphisms (SNPs) in high-mobility group box 1 (HMGB1) gene in patients with oral squamous cell carcinoma (OSCC) and oral lichen planus (OLP). MATERIALS AND METHODS The study was conducted on 93 patients with OSCC, 53 patients with OLP, and 100 controls, all Caucasians of the same ethnicity, matched by age. HMGB1 genotypes for 4 SNPs, 2262G/A (rs1045411), 1177G/C (rs3742305), 3814C/G (rs2249825), and rs4540927, were assessed using TaqMan SNP Genotyping Assays, Applied Biosystems. RESULTS The HMGB1 1177GG genotype was associated with lymph-node metastasis and tumor stage in OSCCs (P = 0.016 and P = 0.030, respectively). Genotype 1177GG resulted in poorer recurrence-free survival (RFS), P = 0.000. The 1177G/C polymorphism was an independent predictor of RFS compared to GG genotype, P = 0.001. The three polymorphisms were in linkage disequilibrium (LD). The AGC and GGC haplotypes were associated with an increased oral cancer risk, determined over the haplotype odds ratios (HOR = 13.316, P = 0.015, and HOR = 5.769, P = 0.029, respectively). The AGC haplotype was related to erosive OLP progression to OSCC (HOR = 12.179, P = 0.001). CONCLUSIONS HMGB1 polymorphism 1177G/C could be associated with tumor progression and recurrence-free survival in patients with OSCC. The haplotypes of HMGB1 gene might be associated with susceptibility to OSCC and OLP progression to OSCC.

[1]  Peter A Keyel,et al.  How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1. , 2014, Cytokine.

[2]  Juan Chen,et al.  Association of HMGB1 and HMGB2 genetic polymorphisms with lung cancer chemotherapy response , 2014, Clinical and experimental pharmacology & physiology.

[3]  Yu-ming Wang,et al.  HMGB1 gene polymorphisms in patients with chronic hepatitis B virus infection. , 2013, World journal of gastroenterology.

[4]  K. Tatsch,et al.  Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients , 2013, International journal of cancer.

[5]  Sang‐Gun Ahn,et al.  Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis. , 2012, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[6]  M. Lotze,et al.  High‐mobility group box 1 activates caspase‐1 and promotes hepatocellular carcinoma invasiveness and metastases , 2012, Hepatology.

[7]  A. Kotsinas,et al.  Oral Lichen Planus as a Preneoplastic Inflammatory Model , 2012, Journal of biomedicine & biotechnology.

[8]  S. Lang,et al.  HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer. , 2012, Oral oncology.

[9]  A. Zhang,et al.  Clinical relevance of single nucleotide polymorphisms of the high mobility group box 1 protein gene in patients with major trauma in southwest China. , 2012, Surgery.

[10]  Donghai Huang,et al.  Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance. , 2010, European journal of cancer.

[11]  H. Sengeløv,et al.  Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  C. Scully,et al.  Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. , 2009, Oral diseases.

[13]  P. Rovere-Querini,et al.  HMGB1: a two-headed signal regulating tumor progression and immunity. , 2008, Current opinion in immunology.

[14]  Yan Ding,et al.  Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma , 2008, The Journal of pathology.

[15]  A. Bosserhoff,et al.  High mobility group box‐1‐inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma , 2008, Cancer science.

[16]  D. Green,et al.  Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. , 2008, Immunity.

[17]  P. Garred,et al.  Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome , 2008, Critical care.

[18]  J. Gil-Montoya,et al.  Oral lichen planus: controversies surrounding malignant transformation. , 2008, Oral diseases.

[19]  S. Warnakulasuriya,et al.  Nomenclature and classification of potentially malignant disorders of the oral mucosa. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[20]  Laurence Zitvogel,et al.  Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.

[21]  P. Garred,et al.  The genetic variation of the human HMGB1 gene. , 2007, Tissue antigens.

[22]  D. A. Tregouet,et al.  A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies , 2007, Bioinform..

[23]  L. Ulloa,et al.  High-mobility group box 1 (HMGB1) protein: friend and foe. , 2006, Cytokine & growth factor reviews.

[24]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[25]  S. Müller,et al.  Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function , 2004, Journal of internal medicine.

[26]  H. Uramoto,et al.  Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression. , 2003, The Biochemical journal.

[27]  H. Kuniyasu,et al.  Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer. , 2003, Oncology reports.

[28]  L. Borrmann,et al.  Variation of HMGB1 expression in breast cancer. , 2001, Anticancer research.

[29]  H. Lum,et al.  The human HMGB1 promoter is modulated by a silencer and an enhancer-containing intron. , 2001, Biochimica et biophysica acta.

[30]  H. Takano,et al.  Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells. , 2001, Cancer research.

[31]  Michael Bustin,et al.  Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal Proteins , 1999, Molecular and Cellular Biology.

[32]  Tatsuhiko Tsunoda,et al.  Estimating transcription factor bindability on DNA , 1999, Bioinform..

[33]  N. Testa,et al.  The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. , 1998, Oral oncology.

[34]  M. Rocchi,et al.  The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13. , 1996, Genomics.

[35]  S. Cunningham,et al.  Oral cancer development in patients with oral lichen planus. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[36]  T. Whiteside.  Immunobiology of head and neck cancer , 2005, Cancer and Metastasis Reviews.